Media coverage about Balchem Corporation (NASDAQ:BCPC) has been trending somewhat positive recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Balchem Corporation earned a news sentiment score of 0.10 on Accern’s scale. Accern also assigned news coverage about the basic materials company an impact score of 47.0976435307238 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Balchem Corporation (NASDAQ BCPC) traded down 0.73% on Friday, reaching $74.48. 61,814 shares of the company’s stock traded hands. Balchem Corporation has a 52-week low of $65.37 and a 52-week high of $89.50. The firm’s 50-day moving average is $77.35 and its 200 day moving average is $80.84. The stock has a market capitalization of $2.38 billion, a PE ratio of 38.59 and a beta of 1.10.

Balchem Corporation (NASDAQ:BCPC) last announced its quarterly earnings results on Friday, August 4th. The basic materials company reported $0.64 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.63 by $0.01. Balchem Corporation had a net margin of 10.99% and a return on equity of 14.99%. The firm had revenue of $147.08 million for the quarter. Analysts forecast that Balchem Corporation will post $2.48 EPS for the current year.

Separately, BidaskClub cut shares of Balchem Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, June 21st.

TRADEMARK VIOLATION WARNING: “Balchem Corporation (NASDAQ:BCPC) Given Media Sentiment Rating of 0.10” was originally reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at

In other news, Director Edward Mcmillan sold 2,557 shares of the business’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $81.09, for a total value of $207,347.13. Following the sale, the director now owns 25,739 shares of the company’s stock, valued at $2,087,175.51. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 1.59% of the company’s stock.

About Balchem Corporation

Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.

Insider Buying and Selling by Quarter for Balchem Corporation (NASDAQ:BCPC)

Receive News & Ratings for Balchem Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.